Connection
Sean Davis to Heterografts
This is a "connection" page, showing publications Sean Davis has written about Heterografts.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.027 |
|
|
|
-
Boufraqech M, Nilubol N, Zhang L, Gara SK, Sadowski SM, Mehta A, He M, Davis S, Dreiling J, Copland JA, Smallridge RC, Quezado MM, Kebebew E. miR30a inhibits LOX expression and anaplastic thyroid cancer progression. Cancer Res. 2015 Jan 15; 75(2):367-77.
Score: 0.027